Keywords: Takeda, None months 2010 financial results
Generics and stronger yen take toll on Takeda’s nine-month 2010 earnings
Article | 03 February 2011
Japan’s largest drugmaker, Takeda Pharmaceuticals (TSE: 4502), posted disappointing results for the first nine months of 2010, with net income ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
